Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M123,440Revenue $M34,858Net Margin (%)12.0Z-Score2.2
Enterprise Value $M143,675EPS $0.9Operating Margin %15.6F-Score5
P/E(ttm))27.6Cash Flow Per Share $0Pre-tax Margin (%)12.9Higher ROA y-yN
Price/Book19.410-y EBITDA Growth Rate %0.5Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-5.1Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-43.6ROA % (ttm)6.8Higher Current Ratio y-yN
Dividend Yield %5.4Insider Buy (3m)0ROE % (ttm)47.5Less Shares Outstanding y-yY
Payout Ratio %141Shares Outstanding M5,355ROI % (ttm)14.0Gross Margin Increase y-yY

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

GLAXF is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$225.86 view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1410.17 view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29340.26 view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1294.08 view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1466.36 view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1294.08 view

Press Releases about GLAXF :

    Quarterly/Annual Reports about GLAXF:

      News about GLAXF:

      Articles On GuruFocus.com
      Taking a Closer Look at GlaxoSmithKline Apr 22 2015 
      British Stock Picks From Gurus During Q4 Mar 24 2015 
      Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
      Bestinfond Adds More Than a Dozen Foreign Stocks to Portfolio Mar 06 2015 
      Causeway International Value Fund Adds 2 New Stocks Mar 03 2015 
      Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
      Dodge & Cox 2014 Equity Year in Review Feb 19 2015 
      Bestinfond's Top 5 New Buys During Q4 Feb 03 2015 
      Can GlaxoSmithKline Continue Striving in the Face of World Challenges? Jan 30 2015 
      Tumor Drug Takes The Focus At OncoMed Pharmaceuticals Jan 29 2015 

      More From Other Websites
      U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug May 01 2015
      GSK expected to can capital return plan amid stagnant growth May 01 2015
      5 Toxic Stocks to Sell in May May 01 2015
      Doubts grow over GlaxoSmithKline's $6 bln capital return plan May 01 2015
      Doubts grow over GlaxoSmithKline's $6 bln capital return plan May 01 2015
      Doubts grow over GlaxoSmithKline's 4 billion pound capital return plan May 01 2015
      Doubts grow over GlaxoSmithKline's $6 bln capital return plan May 01 2015
      Doubts grow over GlaxoSmithKline's $6 bln capital return plan May 01 2015
      The Real Reason HSBC Holdings plc Will Return To Hong Kong: Shareholders In Diageo plc And... May 01 2015
      U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug Apr 30 2015
      U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug Apr 30 2015
      GSK wins approval for asthma drug; will be produced in Zebulon Apr 30 2015
      Glaxo Wins U.S. Approval to Sell Breo Only to Adults With Asthma Apr 30 2015
      Glaxo gets OK to expand marketing of inhaler drug Apr 30 2015
      Glaxo gets OK to expand marketing of inhaler drug Apr 30 2015
      Why I Would Buy GlaxoSmithKline plc And Royal Mail PLC But Sell James Fisher & Sons plc Apr 30 2015
      Intellectual Property Rights For Global Health Apr 29 2015
      Is BP plc Less Risky Than GlaxoSmithKline plc & ARM Holdings plc Right Now? Apr 29 2015
      Chinese chase Australian opiates in Hong Kong Apr 28 2015
      Takeda to pay $2.7bn to settle Actos cancer claims Apr 28 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK